Nonconformance & Deviation Review Services for Medical Devices
Strengthen your quality system with expert nonconformance and deviation review support tailored to medical device manufacturers. Elexes helps teams classify events correctly, document defensible decisions, connect findings to CAPA and risk management, and stay inspection-ready across FDA, ISO 13485, EU MDR, and other global requirements.
Our Nonconformance & Deviation Review Services
Targeted quality and regulatory support for reviewing, documenting, and resolving medical device quality events.
Deviation Review
Guidance for evaluating production deviations, process nonconformances, and quality events with proper classification, disposition, documentation, and escalation criteria aligned to your quality procedures.
Change Impact Assessment
Structured assessment of proposed or implemented changes to determine regulatory impact, required submissions, and defensible documentation across FDA, EU MDR, TGA, and other markets.
CAPA Review
Independent review of CAPA quality, including root cause logic, action adequacy, effectiveness checks, and closure readiness when deviations or nonconformances indicate systemic issues.
Complaint Governance
Ongoing support for complaint classification, investigation adequacy, reportability assessment, and linkage between complaint records, nonconformances, and post-market obligations.
RMF/DHF Remediation
Focused remediation of risk management and design history files to restore traceability, close documentation gaps, and support audit-defensible quality event decisions.
Internal Audits
Periodic internal audits to identify compliance gaps, evaluate inspection readiness, and verify that deviation, nonconformance, and CAPA processes are functioning effectively.
Our Structured Review Process
Review the quality event
We examine the deviation or nonconformance record, supporting evidence, affected product or process, and existing procedures to confirm the event is clearly defined and documented from the start.
Classify and assess impact
Our consultants determine the correct event classification, evaluate product and patient risk, and assess whether the issue affects compliance, release decisions, reportability, or previously authorized device status.
Define investigation expectations
We identify what investigation depth is required, what records must be reviewed, and whether the event points to isolated error, recurring process weakness, supplier issue, or broader quality system failure.
Link to CAPA and risk files
Where needed, we connect the event to CAPA, complaint handling, risk management, DHF, RMF, or change control so your documentation remains traceable and inspection-ready.
Document defensible closure
We support clear disposition, rationale, and closure documentation that can withstand FDA inspections, ISO 13485 audits, and global regulatory scrutiny without unnecessary over-escalation.
Trusted By Manufacturers
Success Stories
See how medical device teams improve compliance confidence and audit readiness with expert regulatory support.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Medical device companies rely on Elexes for disciplined, regulator-aware quality event review support.
Deep Expertise
50+ years of collective experience across medical device regulatory and quality systems.
Global Alignment
Reviews are aligned to FDA, ISO 13485, EU MDR, TGA, and other market expectations.
Traceable Decisions
We connect deviations to CAPA, risk files, complaints, and change control when required.
Flexible Support
Project-based, part-time, or embedded RAQA support without adding permanent headcount.
Meet The Elexes Team
Experienced consultants supporting complex medical device quality systems.
Elexes is a trusted medical device regulatory and quality consulting partner supporting manufacturers across the full product lifecycle. The team works with companies ranging from startups to established global brands, helping them strengthen quality systems, prepare submissions, respond to regulatory scrutiny, and maintain compliant post-market operations. With 50+ years of collective experience, Elexes brings practical expertise across FDA, ISO 13485, EU MDR, TGA, Health Canada, and other frameworks. Their approach combines regulatory depth with operational discipline, allowing clients to resolve documentation gaps, improve audit readiness, and make defensible quality decisions without slowing business momentum. From targeted remediation to embedded RAQA support, Elexes helps organizations build systems that stand up to real-world review.
200+ Product TypesExperience spanning a wide range of medical technologies.250+ Successful ProjectsDelivered across diverse regulatory and quality engagements.90% Audit Clearance RateStrong track record supporting inspection and audit readiness.
Frequently Asked Questions
What is the difference between deviation and nonconformance?
A deviation is a departure from an approved process, procedure, instruction, or specification during operations. A nonconformance is a failure of a product, material, process, or system to meet defined requirements. In practice, deviations often focus on what went off-procedure, while nonconformances focus on what failed acceptance criteria. Both require documented review, impact assessment, and appropriate disposition.
What are the 4 types of deviation?
Organizations commonly group deviations into planned deviations, unplanned deviations, temporary deviations, and recurring or systemic deviations. The exact categories can vary by quality system, but the purpose is the same: classify the event correctly so review depth, approvals, risk assessment, and CAPA escalation are handled consistently. A strong procedure should define each type and the required documentation path.
When should a deviation be escalated to CAPA?
A deviation should be escalated to CAPA when it indicates a recurring issue, systemic process weakness, ineffective controls, significant product or patient risk, or a trend that cannot be justified as isolated. CAPA is also appropriate when root cause analysis shows broader quality system impact. Proper escalation ensures corrective actions, effectiveness checks, and management visibility are formally documented.
How do you determine whether a nonconformance affects released product?
The review should assess affected lots or units, traceability records, acceptance data, complaint history, distribution status, and the nature of the requirement that was not met. Teams also evaluate whether the issue changes safety, performance, labeling, sterility, software behavior, or regulatory commitments. A defensible assessment documents scope, rationale, and any required containment, field action, or reportability decision.
What documentation is typically reviewed during a deviation investigation?
Typical records include the deviation report, batch or device history records, work instructions, SOPs, training records, equipment logs, calibration records, environmental data, supplier records, test results, and prior related events. Depending on the issue, reviewers may also examine CAPAs, complaints, risk management files, DHF records, and change controls. The goal is to establish facts, impact, root cause, and closure rationale.
Can a deviation be closed without a full investigation?
Yes, but only when the event is minor, clearly understood, low risk, and supported by objective evidence showing no broader product or process impact. Even then, the rationale for limited investigation must be documented and approved under the quality system procedure. If there is uncertainty, recurrence, or possible compliance impact, a deeper investigation and possible CAPA linkage are usually warranted.
How do deviation reviews support FDA and ISO 13485 compliance?
Well-run deviation reviews show that the manufacturer identifies quality events promptly, evaluates impact systematically, documents decisions clearly, and escalates issues appropriately. That supports core expectations under FDA quality system requirements and ISO 13485 for control of nonconforming product, corrective action, records, and risk-based decision-making. Inspectors look for consistency, traceability, timeliness, and evidence that issues are not being minimized.
What should a strong nonconformance review process include?
A strong process includes clear event definitions, standardized classification rules, timely containment, documented impact assessment, investigation criteria, disposition pathways, CAPA escalation thresholds, approval requirements, and closure checks. It should also connect to complaints, risk management, change control, and post-market surveillance where relevant. The best systems produce consistent decisions and records that are easy to defend during audits or inspections.
Still Have Questions?
Talk with our medical device quality and regulatory specialists.
Global Service Coverage
Elexes supports medical device manufacturers across major regulated markets with flexible remote consulting and embedded RAQA support.
USA, UK, Europe & More
Service Reach
250+ Successful Projects
Project Experience
100+ Global Clients
Client Coverage
USA
UK
Europe
Canada
Australia
California
Need Support In Your Market?
Ask about coverage for your products and regulatory jurisdictions.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise.
MDSAP
Supports multi-market audit readiness.
IEC 62304
Software lifecycle compliance expertise.
